Menaderm Simplex (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Menaderm Simplex, is a corticosteroid presented as a topical anti‑inflammatory for topical use. It treats inflammatory skin conditions such as psoriasis, atopic dermatitis and contact dermatitis in adults and children as prescribed.

GNH USA supplies Menaderm Simplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Beclometasone dipropionate is a topical corticosteroid used to manage inflammatory skin disorders.

- Psoriasis: reduces scaling, erythema and plaque thickness. - Atopic dermatitis: alleviates itching, redness and inflammation. - Contact dermatitis: diminishes local swelling and irritation.

Adverse reactions are generally limited to the application site, but systemic effects can occur with extensive use.

Common Side Effects: - Burning or stinging sensation at the site of application. - Pruritus or mild itching. - Dryness or flaking of the skin. - Folliculitis or acneiform eruptions. - Erythema or mild redness.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Contact hypersensitivity or allergic reaction. - Secondary bacterial, fungal or viral infection of the skin.

Before using Menaderm Simplex, consider the following safety measures.

- Apply to affected area only: avoid healthy skin and mucous membranes. - Avoid use on infected or ulcerated skin: risk of systemic absorption increases. - Do not cover with occlusive dressings unless directed: may enhance drug penetration. - Limit duration of therapy: prolonged use raises risk of local side effects. - Monitor for systemic effects in extensive or high‑dose applications. - Store at room temperature: keep in the original container, protect from moisture and light.

Beclometasone dipropionate may interact with other agents that affect corticosteroid metabolism or immune function.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase local drug concentration. - Live vaccines: topical immunosuppression could reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Other topical immunosuppressants (e.g., tacrolimus): overlapping immunosuppressive activity. - Phototherapy: combined treatment may increase skin irritation. - Antifungal or antiviral topical agents: potential for altered absorption.